Private equity firms have increased their investment in health care in recent years, with an estimated $1 trillion global deal value in 2021 compared to $469 billion in 2020.1 Private equity firms invest in non-publicly traded companies and typically focus on already profitable companies with potential for significant financial growth. After acquisition, firms will commonly deploy strategies to maximize profit, including consolidation and increasing procedural volumes. This study aimed to investigate whether private equity acquisition of urologic practices increased the volume of common outpatient urologic procedures.
Read the full article: Private Equity Acquisition Effect on the Most Common Urologic Procedures //
Source: https://www.sciencedirect.com/science/article/abs/pii/S0090429526004929